291 related articles for article (PubMed ID: 38101776)
21. Risk of macrophage activation syndrome in patients with adult-onset Still's disease with skin involvement: A retrospective cohort study.
Ding Y; Tang S; Li S; Yang C; Liu T; Ying S; Zhu D; Sun C; Chen W; Shi Y; Fang H; Qiao J
J Am Acad Dermatol; 2021 Dec; 85(6):1503-1509. PubMed ID: 33556412
[TBL] [Abstract][Full Text] [Related]
22. Adult-onset Still's disease or systemic-onset juvenile idiopathic arthritis and spondyloarthritis: overlapping syndrome or phenotype shift?
Mitrovic S; Hassold N; Kamissoko A; Rosine N; Mathian A; Mercy G; Pertuiset E; Nocturne G; Fautrel B; Koné-Paut I
Rheumatology (Oxford); 2022 May; 61(6):2535-2547. PubMed ID: 34559214
[TBL] [Abstract][Full Text] [Related]
23. Molecular genetic analysis for periodic fever syndromes: a supplemental role for the diagnosis of adult-onset Still's disease.
Li H; Abramova I; Chesoni S; Yao Q
Clin Rheumatol; 2018 Aug; 37(8):2021-2026. PubMed ID: 29909561
[TBL] [Abstract][Full Text] [Related]
24. Predictive factors and prognosis of macrophage activation syndrome associated with adult-onset Still's disease.
Yang XP; Wang M; Li TF; Li W; Zhang L; Liu SY
Clin Exp Rheumatol; 2019; 37 Suppl 121(6):83-88. PubMed ID: 31287402
[TBL] [Abstract][Full Text] [Related]
25. The 4th NextGen Therapies for SJIA and MAS: part 1 the elephant in the room: diagnostic/classification criteria for systemic juvenile idiopathic arthritis and adult-onset still's disease.
Nigrovic PA; de Benedetti F; Kimura Y; Lovell DJ; Vastert SJ
Pediatr Rheumatol Online J; 2024 Jan; 21(Suppl 1):114. PubMed ID: 38183114
[TBL] [Abstract][Full Text] [Related]
26. In-hospital mortality in febrile lupus patients based on 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome.
Ahn SS; Yoo BW; Jung SM; Lee SW; Park YB; Song JJ
Semin Arthritis Rheum; 2017 Oct; 47(2):216-221. PubMed ID: 28268026
[TBL] [Abstract][Full Text] [Related]
27. Elevated serum gasdermin D N-terminal implicates monocyte and macrophage pyroptosis in adult-onset Still's disease.
Nagai H; Kirino Y; Nakano H; Kunishita Y; Henmi R; Szymanski AM; Yoshimi R; Ombrello MJ; Nakajima H
Rheumatology (Oxford); 2021 Aug; 60(8):3888-3895. PubMed ID: 33550379
[TBL] [Abstract][Full Text] [Related]
28. Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still's disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort.
Di Benedetto P; Cipriani P; Iacono D; Pantano I; Caso F; Emmi G; Grembiale RD; Cantatore FP; Atzeni F; Perosa F; Scarpa R; Guggino G; Ciccia F; Giacomelli R; Ruscitti P
PLoS One; 2020; 15(7):e0235326. PubMed ID: 32645077
[TBL] [Abstract][Full Text] [Related]
29. Clinical characteristics of macrophage activation syndrome in adult-onset Still's disease.
Gao Q; Yuan Y; Wang Y; Jiang J; Ye Z; Liu T; Jiang Z; Zhao L
Clin Exp Rheumatol; 2021; 39 Suppl 132(5):59-66. PubMed ID: 34251315
[TBL] [Abstract][Full Text] [Related]
30. [Still's syndrome-similarities and differences between the juvenile and adult forms].
Regel A; Föll D; Kriegel MA
Z Rheumatol; 2022 Feb; 81(1):22-27. PubMed ID: 34735597
[TBL] [Abstract][Full Text] [Related]
31. Clinical and laboratory features, treatment, and outcomes of macrophage activation syndrome in 80 children: a multi-center study in China.
Zou LX; Zhu Y; Sun L; Ma HH; Yang SR; Zeng HS; Xiao JH; Yu HG; Guo L; Xu YP; Lu MP
World J Pediatr; 2020 Feb; 16(1):89-98. PubMed ID: 31612427
[TBL] [Abstract][Full Text] [Related]
32. [Clinical characteristics and treatment outcomes of macrophage activation syndrome in adults: A case series of 67 patients].
Yao HH; Wang YN; Zhang X; Zhao JX; Jia Y; Wang Z; Li ZG
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 51(6):996-1002. PubMed ID: 31848493
[TBL] [Abstract][Full Text] [Related]
33. Cytokine profile, ferritin and multi-visceral involvement characterize macrophage activation syndrome during adult-onset Still's disease.
Ruscitti P; Ursini F; Berardicurti O; Masedu F; Bozzalla Cassione E; Naldi S; Di Cola I; Di Muzio C; De Stefano L; Di Nino E; Navarini L; Vomero M; Bugatti S; Valenti M; Mariani E; Iagnocco A; Montecucco C; Giacomelli R; Cipriani P
Rheumatology (Oxford); 2022 Dec; 62(1):321-329. PubMed ID: 35438139
[TBL] [Abstract][Full Text] [Related]
34. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
Ravelli A; Minoia F; Davì S; Horne A; Bovis F; Pistorio A; Aricò M; Avcin T; Behrens EM; De Benedetti F; Filipovic L; Grom AA; Henter JI; Ilowite NT; Jordan MB; Khubchandani R; Kitoh T; Lehmberg K; Lovell DJ; Miettunen P; Nichols KE; Ozen S; Pachlopnik Schmid J; Ramanan AV; Russo R; Schneider R; Sterba G; Uziel Y; Wallace C; Wouters C; Wulffraat N; Demirkaya E; Brunner HI; Martini A; Ruperto N; Cron RQ; ; ; ;
Ann Rheum Dis; 2016 Mar; 75(3):481-9. PubMed ID: 26865703
[TBL] [Abstract][Full Text] [Related]
35. Serum β2-microglobulin level is a useful indicator of disease activity and hemophagocytic syndrome complication in systemic lupus erythematosus and adult-onset Still's disease.
Wakabayashi K; Inokuma S; Matsubara E; Onishi K; Asashima H; Nakachi S; Hagiwara K
Clin Rheumatol; 2013 Jul; 32(7):999-1005. PubMed ID: 23504210
[TBL] [Abstract][Full Text] [Related]
36. Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis.
Kostik MM; Dubko MF; Masalova VV; Snegireva LS; Kornishina TL; Chikova IA; Likhacheva TS; Isupova EA; Glebova NI; Kuchinskaya EM; Balbotkina EV; Buchinskaya NV; Kalashnikova OV; Chasnyk VG
Semin Arthritis Rheum; 2015 Feb; 44(4):417-22. PubMed ID: 25300700
[TBL] [Abstract][Full Text] [Related]
37. Evaluating the multivisceral involvement on adult-onset Still's disease to retrieve imaging-based differences in patients with and without macrophage activation syndrome: results from a single-centre observational study.
Di Cola I; Bruno F; Berardicurti O; Monti R; Conforti A; Di Sibio A; Pavlych V; Masciocchi C; Barile A; Cipriani P; Ruscitti P
Clin Rheumatol; 2021 Oct; 40(10):3971-3978. PubMed ID: 33855668
[TBL] [Abstract][Full Text] [Related]
38. Is it possible to predict a disease course prone to macrophage activation syndrome at systemic juvenile idiopathic arthritis diagnosis?
Batu ED; Sener S; Balık Z; Bayındır Y; Cam V; Kasap Cuceoglu M; Uysal O; Aliyev E; Basaran Ö; Bilginer Y; Özen S
Clin Rheumatol; 2024 Jan; 43(1):415-421. PubMed ID: 38012469
[TBL] [Abstract][Full Text] [Related]
39. Case Report: A Rare Case of Elderly-Onset Adult-Onset Still's Disease in a Patient With Systemic Lupus Erythematosus.
Hirooka Y; Okuda S; Sugiyama M; Shiga T; Nozaki Y; Kinoshita K; Funauchi M; Matsumura I
Front Immunol; 2022; 13():822169. PubMed ID: 35116046
[TBL] [Abstract][Full Text] [Related]
40. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 20 Moroccan adult patients.
Wafa A; Hicham H; Naoufal R; Hajar K; Rachid R; Souad B; Mouna M; Zoubida MT; Mohamed A
Clin Rheumatol; 2022 Jul; 41(7):2021-2033. PubMed ID: 35179662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
